This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
Cardiovascular diabetology, 18(1), 73
Citation
Leiter, Lawrence A; Bain, Stephen C; Hramiak, Irene; Jódar, Esteban; Madsbad, Sten; Gondolf, Theis; Hansen, Thomas; Holst, Ingrid; Lingvay, Ildiko. (2019). Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.. Cardiovascular diabetology, 18(1), 73. https://doi.org/10.1186/s12933-019-0871-8